These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24334406)

  • 1. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
    Holy EW; Jakob P; Eickner T; Camici GG; Beer JH; Akhmedov A; Sternberg K; Schmitz KP; Lüscher TF; Tanner FC
    Eur Heart J; 2014 Mar; 35(12):808-20. PubMed ID: 24334406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation.
    Ota H; Eto M; Ako J; Ogawa S; Iijima K; Akishita M; Ouchi Y
    J Am Coll Cardiol; 2009 Jun; 53(24):2298-305. PubMed ID: 19520256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
    Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
    Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.
    Fukuda D; Enomoto S; Shirakawa I; Nagai R; Sata M
    Eur J Pharmacol; 2009 Jun; 612(1-3):87-92. PubMed ID: 19371739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents.
    Camici GG; Steffel J; Akhmedov A; Schafer N; Baldinger J; Schulz U; Shojaati K; Matter CM; Yang Z; Lüscher TF; Tanner FC
    Circulation; 2006 Oct; 114(14):1512-21. PubMed ID: 17000906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.
    Jing L; Wang W; Zhang S; Xie M; Tian D; Luo X; Wang D; Ning Q; Lü J; Wang W
    PLoS One; 2015; 10(3):e0118826. PubMed ID: 25760326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
    Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.
    Kapopara PR; von Felden J; Soehnlein O; Wang Y; Napp LC; Sonnenschein K; Wollert KC; Schieffer B; Gaestel M; Bauersachs J; Bavendiek U
    Thromb Haemost; 2014 Dec; 112(6):1264-76. PubMed ID: 25120198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local insulin application on the carotid artery inhibits neointima formation.
    Chiang S; Breen DM; Guo J; Mori Y; Giacca A
    Can J Physiol Pharmacol; 2013 Dec; 91(12):1086-94. PubMed ID: 24289080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kruppel-like factor 2 might mediate the rapamycin-induced arterial thrombosis in vivo: implications for stent thrombosis in patients.
    Nie XM; Su LX; Xu RX; Guo YL; Zhou YJ; Li JJ
    Chin Med J (Engl); 2013 Jul; 126(14):2636-40. PubMed ID: 23876886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.
    Carmeliet P; Moons L; Lijnen R; Janssens S; Lupu F; Collen D; Gerard RD
    Circulation; 1997 Nov; 96(9):3180-91. PubMed ID: 9386191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
    Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
    Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.